Proteostasis Therapeutics’s Global License Agreement with Genentech

Ambrogio Visconti

Goodwin advised Proteostasis Therapeutics on its worldwide, exclusive license agreement with Genentech for rights to potential therapeutic small molecule modulators of an undisclosed target within the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now